Luminus Management LLC Mersana Therapeutics, Inc. Transaction History
Luminus Management LLC
- $99.8 Million
- Q2 2025
A detailed history of Luminus Management LLC transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Luminus Management LLC holds 1,039,314 shares of MRSN stock, worth $6.31 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
1,039,314Holding current value
$6.31 Million% of portfolio
0.31%Shares
1 transactions
Others Institutions Holding MRSN
# of Institutions
89Shares Held
95.6MCall Options Held
34.3KPut Options Held
14K-
Nextech Invest Ag12.1MShares$73.2 Million3.22% of portfolio
-
Nextech Invest, Ltd. Zurich, V812.1MShares$73.2 Million0.68% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA8.66MShares$52.6 Million0.78% of portfolio
-
Black Rock Inc. New York, NY8.38MShares$50.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.68MShares$46.6 Million0.0% of portfolio
About Mersana Therapeutics, Inc.
- Ticker MRSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,169,296
- Market Cap $590M
- Description
- Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...